Search hospitals > California > Montclair
Catalina Research Institute, LLC
Claim this profileMontclair, California 91763
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Fatty Liver Disease
Conducts research for Non-alcoholic Fatty Liver Disease
Conducts research for Liver Disease
107 reported clinical trials
2 medical researchers
Summary
Catalina Research Institute, LLC is a medical facility located in Montclair, California. This center is recognized for care of Diabetes, Type 2 Diabetes, Fatty Liver Disease, Non-alcoholic Fatty Liver Disease, Liver Disease and other specialties. Catalina Research Institute, LLC is involved with conducting 107 clinical trials across 59 conditions. There are 2 research doctors associated with this hospital, such as Rizwana H Mohseni and Stephen Volk, MD.Top PIs
Rizwana H MohseniCatalina Research Institute, LLC3 years of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
15 reported clinical trials
18 drugs studied
Stephen Volk, MDCatalina Research Institute, LLC1 year of reported clinical research
Studies Major Depressive Disorder
1 reported clinical trial
1 drug studied
Clinical Trials running at Catalina Research Institute, LLC
Type 2 Diabetes
Obesity
Non-alcoholic Fatty Liver Disease
Diabetes
Fatty Liver Disease
Liver Disease
Fungal Nail Infection
Chronic Kidney Disease
Major Depressive Disorder
Obstructive Sleep Apnea
Tirzepatide
for Type 2 Diabetes
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.
Recruiting3 awards Phase 43 criteria
BMF-219
for Type 2 Diabetes
A Phase 1/ 2 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMF-219, an Oral Covalent Menin Inhibitor, in Healthy Adult Subjects and in Adult Subjects with Type 2 Diabetes Mellitus.
Recruiting1 award Phase 1 & 216 criteria
HU6
for Type 2 Diabetes with Risk of Fatty Liver Disease
This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in obese subjects with type 2 diabetes (T2D) at risk of nonalcoholic steatohepatitis (NASH). Six months (26 weeks) of dosing is planned, and subjects will be followed for safety, efficacy, pharmacodynamics (PD), and pharmacokinetics (PK) during this time. The end-of-study visit will take place approximately 4 weeks after the last dose of the study drug (Week 30).
Recruiting0 awards Phase 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Catalina Research Institute, LLC?
Catalina Research Institute, LLC is a medical facility located in Montclair, California. This center is recognized for care of Diabetes, Type 2 Diabetes, Fatty Liver Disease, Non-alcoholic Fatty Liver Disease, Liver Disease and other specialties. Catalina Research Institute, LLC is involved with conducting 107 clinical trials across 59 conditions. There are 2 research doctors associated with this hospital, such as Rizwana H Mohseni and Stephen Volk, MD.